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Thalassemia syndromes are the most common single-gene disorder worldwide. About 3% of the world population (150 million) carries the thalassemia genes. In Egypt, 
β-thalassemia is the most common genetically determined, chronic, 
hemolytic anemia, and carrier rate are estimated to be 8.5–10% [1,2]. 
Screening programs have been adapted to meet the needs of different 
communities and seem to reflect acceptable cultural practices. 
Screening is either mandatory for all couples before marriage or 
voluntary in high schools, before pregnancy and antenatally [3]. 
However, Egypt has a high level of consanguineous marriages which 
prevents proper premarital screening. Another obstacle is the high 
cost of genetic testing compared to the target population size and 
country resources. Apart from the socioeconomic burden, the quality 
of life of β-thalassemic patients is far behind their healthy peers [4].
Screening for β-thalassemia is technically difficult, mainly 
due to its genetic heterogeneity and the absence of a single 
pathognomonic finding to cover all variants. Despite these 
difficulties, many screening attempts have been made where 
differentiation from iron deficiency (ID) was most important. 
The most reliable methods for diagnosis of thalassemia trait (TT) 
include quantitative determination of hemoglobin A2 (HbA2), 
hemoglobin F, globin chain synthetic ratios, and DNA studies for 
specific mutations. These methods, though accurate, could not be 
a tool for initial mass screening [5,6]. Indices can be used in this 
context to detect subjects who would require appropriate follow-up 
and reduce unnecessary costs. The data published for younger age 
groups regarding discriminative power of indices are less, compared 
to adults. An ideal discrimination index has variable sensitivity and 
specificity in different ethnicities [2,7].
There is a paucity of data regarding screening the pediatric age 
group as most of the successful screening programs that led to the 
eradication of the disease were done in adulthood as mandatory 
premarital programs [8]. This makes it important to set the proper 
values on which the screening is made and to test the already 
validated indices on the current population, especially when 
attempting to screen the pediatric group. The study was conducted 
to test the validity of different blood indices and formulas derived 
from automated hematology analyzer in predicting β-TT (BTT) 
and differentiate it from ID.
MATERIALS AND METHODS
A cross-sectional descriptive study was conducted in Elshat by 
pediatric hospital and the subjects were screened for the duration 
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of 6 months starting from January 2017. A random selection of 200 
children was done based on their non-hematological complaints 
such as infections, allergies, and rickets. Exclusion criteria were 
having a sibling with thalassemia major and chronic illnesses 
such as renal, cardiac, hepatic, and tuberculosis. Complete history 
was taken for all children. Complete blood picture was done on 
Advia Sysmex analyzer, Hb electrophoresis on Sebia Capillarys 
2 instrument, iron study in the form of serum iron, and total iron-
binding capacity (TIBC). Mutation analysis for β-thalassemia 
was done by sequence-specific oligonucleotide hybridization for 
the common mutations for selected cases.
Children were classified into microcytic and non-microcytic 
anemic patients, if Hb was <11 gm/dl and mean corpuscular 
volume (MCV) value <70 fl. For Hb electrophoresis, a cutoff 
was taken of 3.2% above which patients were classified as TT. 
Cases with HbA2 3.2–3.5% were subjected to gene mutation 
analysis. Children with serum iron of <55 mg/dl with a normal 
electrophoresis were diagnosed as ID anemia after documenting 
response to iron therapy. For the ID cases, electrophoresis was 
repeated after completion of iron therapy. The following indices 
were used to classify patients: Mentzer (MCV/RBC), England 
and Fraser (MCV–RBC – 5 × Hb – 3.4), Shine and Lal (MCV2 × 
MCH/100), Ehsani (MCV-10 × RBC), Srivastava (MCH/RBC), 
Green and King formula MCV2 × Red blood cell distribution 
width (RDW)/Hb × 100, and RDWI RDW × MCV/RBC [9]. 
The study protocol was approved by the ethics committee at 
Alexandria Faculty of Medicine, and an informed consent 
was obtained from all caregivers of the included children as 
participation was voluntary.
Data were entered and analyzed using IBM SPSS version 20. 
Data were described using number, percentage, mean median, and 
range according to variable type. Comparison between groups 
was done using Chi-square and Fisher’s exact test for qualitative 
data and Kruskal–Wallis and Mann–Whitney tests for quantitative 
data as data were not normally distributed. Analysis was done at 
5% level of significance. Accuracy of different studied indices for 
diagnosis of TT, namely, sensitivity, specificity, and area under the 
curve was tested at different coordinate points to verify the most 
accurate cutoff values using a receiver operating characteristic 
curve. Significance was judged at 0.5.
RESULTS
The age of the studied children ranged from 1 to 15 years with 
a median of 2.5 years. The majority of them (86%) aged from 
1 to 5 years. Based on the results of hemoglobin (Hb) level, Hb 
electrophoresis and serum iron studies were done. Of studied 
children (n=200), the number of confirmed BTT children was 
15/200 (7.5%) while the number of ID was 40/200 (20%). Four 
cases (2%) were common between these two groups.
Eleven cases were confirmed to be TT while 36 cases showed 
typical ID profile with response to treatment. After iron treatment 
and reassessment, another four cases, which were categorized as ID 
proved to be of BTT. Only one case of 16 cases with Hb A2 >3.2 
showed normal genetic pattern. Therefore, the number of confirmed 
BTT children was 15/200 (7.5%) while the number of ID was 
40/200 (20%). Four cases were common between these two groups. 
Our cases were, therefore, divided into four groups; Group A which 
was normal regarding iron profile and Hb electrophoresis, Group B 
with ID anemia, Group C with BTT, and Group D with both.
With respect to Hb level, statistically significant 
difference was detected between Group A (11.7±1.3 g/dl) and 
Groups B and D (9.9±1.5 g/dl). No significant difference was 
found between Groups A and C. With respect to RBCs count, 
a highly significant difference was detected between Group A 
(4.6±0.5 × 106/mm3) and Group C (5.2±0.5 × 106/mm3). In 
addition, a highly significant difference was noticed between 
Group B (3.9±0.5 × 106/mm3) and Group C (5.2 × 106± 0.5). 
RDW was highest in Group B followed by Group C and then 
Group A 14.9 (12.3–20.4), 14.5 (12.7–17.2), and 12.6 (10.6–137), 
respectively. Comparing MCH in different groups, all Groups B, 
C, and D were significantly lower compared to Group A. Similarly, 
Figure 1: Receiver operating characteristic curve for different parameters to predict thalassemia trait versus iron deficiency
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MCV was lower in the three groups compared to normal children. 
Hb distribution width (HDW) showed statistically significant 
difference between Group B and Groups A, C, and D (mean of 
3.5 vs. 2.8, 2.8, and 2.9). We detected cutoffs for different cell 
indices to discriminate ID and TT. We found that HDW at a cutoff 
of 2.94 shows 90% sensitivity, 52% specificity, and area under the 
curve (AUC) of 0.682, while RBC count showed 90% sensitivity 
and 50% specificity at a cutoff of 4.82 × 106/mm3, AUC of 0.691. 
RDW showed 91% sensitivity and 47% specificity, 0.588 AUC.
We further calculated some of the different indices previously 
studied including Mentzer, Shine and Lal, Ehsani, Srivastava, 
England and Fraser, and Green and King. The highest sensitivity 
and specificity were for Ehsani which showed a sensitivity of 
100% and specificity of 61% at a cutoff of 17.5. This was followed 
by Mentzer index at a cutoff of 14 showing sensitivity of 90% and 
specificity of 39%. The other indices could separate groups with 
relatively low specificities (Fig. 1).
DISCUSSION
β-thalassemia has been the most common type of hereditary 
anemia, with a carrier rate of approximately 10%. Of 
1.5 million live births, approximately 1000 babies are born with 
β-thalassemia major annually. In Egypt, the best age for screening 
for thalassemia remains debatable, in addition to many difficulties 
including social stigma and religious considerations. Another 
obstacle to the screening is the costly genetic testing and the lack 
of a single test or index to spot TT with efficient sensitivity and 
specificity.
We aimed at detecting the percentage of thalassemia carriers 
among children attending Elshat by pediatric hospital excluding 
children with hematological disorders and siblings of children 
with β-thalassemia major. We also aimed at detecting the best 
index obtained from complete blood count (CBC) for screening 
in this age group.
All 200 children tested had undergone a CBC on a Sysmex 
machine and were classified as anemic or non-anemic according 
to Hb level of 11 g/dl and were classified as a microcytosis by 
a cutoff of 70 fl. The microcytosis group had 58/200 (29%) 
children. All children were subjected to Hb electrophoresis and 
iron study. Cutoff for HbA2 was taken as 3.2 and further genetic 
testing was done for borderline cases. HbA2 reference range was 
taken as up to 3.2% which was previously studied and validated 
as such on Sebia Capillarys 2 [10]; therefore, we took this value 
as current reference but still did genetic testing for cases whose 
HbA2 was between 3.2% and 3.5%. Iron studies done were serum 
iron and TIBC which showed efficiency in screening for ID in 
pediatric population as reported by Vicinanza et al. [11].
Of the studied cases, 11 were confirmed TT (5.5%), 36 children 
(18%) showed ID anemia while four children showed both 
diseases (2%). Seven cases of the microcytic group showed both 
normal iron profile and HbA2. The total prevalence of BTT in our 
population was, therefore, 7.5% and ID 20%. The rate we detected 
for ID was much lower than reported by an Egyptian investigator 
who reported an incidence of 64% among children from 6 months 
to 12 years of age [12], while the prevalence of β-thalassemia was 
similar to published data [2]. A study done by Chung King Ling 
on a larger population all with thalassemia minor stated that 31% 
of cases had coexisting ID. We hereby determine similarly that 
26.6% of current TT patients had concomitant ID [13].
We further tested the indices derived from CBC parameters 
to discriminate anemia of ID and TT. Similar to Vehapoglu et al., 
we showed that RBC count which was previously considered 
a perfect index for differentiation is not a reliable tool for 
differentiation of ID and BTT as we showed that RBC count 
had only 50% specificity. This may be explained by Aslan and 
Altay observations, who reported that high erythrocyte count is 
common in ID anemia in infants and young children [14,15].
We showed that HDW at the level of 2.94 or less can 
differentiate BTT from iron deficiency anemia (IDA) with 
sensitivity 81.8 and specificity 55.5. The HDW was superior 
to RDW in differentiation of cases of ID and BTT (AUC of 
0.682 vs. 0.588). This is explained by Liu et al. who stated that 
the erythrocyte CH content is constant through different sizes of 
RBCs and concentrations of Hb for a particular individual, as 
demonstrated by direct measurement [16]. d’Onofrio et al. also 
showed that the CH is largely unchanged through reticulocyte 
maturation while the MCV decreases by approximately 20%. 
CH is a better reflection of the state of hemoglobinization during 
erythropoiesis; therefore, the cell hemoglobin distribution width 
is a better indicator of variability than RDW [17].
The current study showed that Ehsani index was superior to 
other indices in differentiating IDA and BTT (100% sensitivity 
and 61% specificity), superior to Mentzer index (90% sensitivity 
and 37% specificity). Contrary to this study, another done 
by Nalbantoğlu et al. showed that the highest sensitivity 
was obtained with Shine and Lal (87.1%), while the highest 
specificity was obtained with E&F formula (100%) [18]. A study 
on Chinese children showed that Green and King index had 
the highest reliability, whereas Srivastava index and Shine and 
Lal index had lowest reliability [19]. Another study in pediatric 
population showed that none of the indices showed sensitivity 
and specificity of 100% in the patients older than 10 years, and 
in the patients younger than 10 years, only Shine and Lal index 
showed sensitivity close to 90% and specificity of 100%. The most 
accurate discriminative index for patients younger than 10 years 
was Shine and Lal and for those older than 10 years, it was RDW 
index. This would probably explain the contradictory results we 
got as current population involved both groups of children above 
and below 10 years of age [20]. Another recent study showed that 
sex differences should be respected when studying indices for 
discriminating ID and TT [21].
Ferrara et al. studied the formulae in differentiating BTT and 
ID and concluded that none of RBC indices or formula appears 
reliable to discriminate between BTT and ID subjects [22]. 
Studies in pediatric age groups are scarce and their results are 
conflicting. Differences in the effectiveness of various RBC 
indices for discriminating 𝛽-TT from IDA could be attributed to 
differences in the mutation spectrum of the thalassemia disease 
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in different populations [23]. Age and sex differences also affect 
these indices.
The current population was selected randomly; therefore, we 
recommend further selection of larger populations detected as ID 
and TT and retrospectively examining their CBCs to determine 
cutoffs and test the efficiency of all known indices on the current 
pediatric population. It is also recommended to test the efficacy of 
using multiple indices and incorporating them into CBC machines 
to give a definitive diagnosis for microcytic anemia.
CONCLUSION
Hemoglobin distribution width is the best parameter obtained 
from complete blood picture to differentiate between children 
with TT and those with ID, while Ehsani index proved to be the 
best index in our studied population.
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